Search NATR
NATURES SUNSHINE PRODUCTS INC
Nasdaq · CIK 275053
Last close12.45
Daily change-0.14 (-1.11%)
10 Years gain-14.85%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NATR · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
69.3Momentum
55.6Acceleration
63.1Confidence
91.0Annual Revenue17
Quarterly Revenue73
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth9.9 / 25
Quality16.7 / 25
Capital Efficiency18.4 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.2 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.3057 percentage points.
Operating leverageOperating margin improved by 1.1146 percentage points.
ROIC expansionROIC improved by 4.8666 percentage points.
Share count reductionDiluted share count declined 2.7008%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM5.77%OK
Revenue CAGR 3Y4.4%OK
Gross Margin72.99%OK
Operating Margin5.85%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC21.95%OK
Incremental Operating Margin 3Y20.91%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.7%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $480.14M | $347.72M | $24.74M | $35.32M | $28.84M | 72.42% | 5.15% | 6.01% | 23.58% | 18.47M |
| 2025 FY Dec 31, 2024 | $454.36M | $324.69M | $20.10M | $25.30M | $14.33M | 71.46% | 4.42% | 3.15% | 17.02% | 19.09M |
| 2024 FY Dec 31, 2023 | $445.32M | $321.13M | $18.75M | $41.23M | $30.75M | 72.11% | 4.21% | 6.9% | 18.43% | 19.47M |
| 2023 FY Dec 31, 2022 | $421.91M | $299.76M | $16.26M | $710,000.00 | -$6.92M | 71.05% | 3.85% | -1.64% | 12.75% | 19.33M |
| 2022 FY Dec 31, 2021 | $444.08M | $328.62M | $34.67M | $34.61M | $27.94M | 74% | 7.81% | 6.29% | 44.92% | 20.33M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $482.97M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-054468, 0000275053-25-000004 |
| Revenue Growth TTM | 5.77% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-054468, 0000275053-25-000004 |
| Revenue CAGR 3Y | 4.4% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-016540 |
| Revenue CAGR 5Y | 4.5% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-016540 |
| Gross Profit CAGR 3Y | 5.07% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-016540 |
| Operating Income Growth | 30.64% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-054468, 0000275053-25-000004 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 72.99% | Gross Profit / Revenue | OK | 0001628280-26-054468, 0000275053-25-000004 |
| Operating Margin | 5.85% | Operating Income / Revenue | OK | 0001628280-26-054468, 0000275053-25-000004 |
| ROIC | 21.95% | NOPAT / Average Invested Capital | OK | 0001628280-26-054468, 0000275053-25-000004 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-054468 |
| Current Ratio | 2.6x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $26.34 | Revenue / Diluted Shares | OK | 0001628280-26-054468, 0000275053-25-000004 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |